Sleep apnea raises risk of cardiovascular events and death

	Pulmonology
	The latest pulmonology news from News Medical

	Sleep apnea raises risk of cardiovascular events and death New research to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) shows that those living with obstructive sleep apnea (OSA) have a 71% higher risk of cardiovascular events (CVEs) or death from any cause (all-cause mortality) compared with those not living with OSA.

	World Health Day 2026: WHO urges global collaboration and science for better health The World Health Organization (WHO) today calls on people everywhere to renew their commitment to working together and supporting science as the twin engines driving better health, under the World Health Day 2026 theme: "Together for health. Stand with science."

			New therapy reprograms immune cells to reduce asthma inflammation A collaborative effort between researchers at the Henan Academy of Innovations in Medical Science, Zhengzhou University, and Shenzhen University School of Medicine has provided the first proof-of-principle study demonstrating that targeting a receptor on the surface of anti-inflammatory regulatory T cells (Tregs) can restore their function and alleviate asthma in mice.

			COCOON trial protocol halves skin toxicities in lung cancer treatment A new research perspective was published in Volume 13 of Oncoscience on March 11, 2026, titled "Early success of the COCOON trial: Preventing dermatologic adverse events in first-line EGFR-mutant NSCLC."

			Lung cancer scans can reveal signs of other undiagnosed cancers When doctors review diagnostic medical scans for lung cancer, they sometimes spot abnormalities unrelated to the lungs.

	Inuit communities urge policy changes to address tuberculosis epidemic Tuberculosis rates for Inuit living in Nunavik, the Inuit lands in northern Quebec, are 1000 times greater than among non-foreign-born Quebeckers, and underresourcing of local health care adds to hardship from the disease, found new research published in CMAJ.

	Northumbria University spinout earns CE mark for breath sampling device A medical device company spun out of Northumbria University has reached a significant milestone — receiving CE marking for a breath sampling platform that peer-reviewed research has demonstrated can reliably collect saliva-free exhaled breath condensates (EBC) from the deep lung, making it the first technology of its type to achieve this distinction.

	New technique can simultaneously treat lung cancer and muscle-wasting condition Researchers at Oregon State University have developed a technique for simultaneously treating lung cancer and a serious muscle-wasting condition that often accompanies it.

	Antibiotic resistance genes found in both diseased and healthy lungs The researchers examined patients with COPD, asthma, pulmonary fibrosis (IPF), and sarcoidosis, and compared them with healthy individuals.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026